Mark Lew
LAC+USC Medical Center(US)Keck Hospital of USC(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders, Restless Legs Syndrome Research, Genetic Neurodegenerative Diseases
Most-Cited Works
- → Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia(1999)444 cited
- → The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension(2017)432 cited
- → A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease(2014)383 cited
- → Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystonia(1999)300 cited
- → Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia(1997)240 cited
- → Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study(2005)239 cited